VX-770
Sponsors
Vertex Pharmaceuticals Incorporated
Conditions
Cystic FibrosisIn Development for Cystic Fibrosis
Phase 1
Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects
CompletedNCT00966602
Start: 2009-09-30End: 2009-12-31Target: 24Updated: 2010-01-05
Study of VX-770 and Rifampin in Healthy Male Subjects
CompletedNCT01018368
Start: 2009-11-30End: 2010-03-31Target: 24Updated: 2010-05-10
Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770
CompletedNCT01060566
Start: 2010-02-28End: 2010-04-30Target: 24Updated: 2010-04-16
Study of VX-770 on Desipramine
CompletedNCT01153542
Start: 2010-06-30End: 2010-08-31Target: 24Updated: 2010-12-09
Study of VX-770 in Subjects With Moderate Hepatic Impairment and in Matched Healthy Subjects
CompletedNCT01208285
Start: 2010-09-30End: 2010-12-31Target: 24Updated: 2011-01-12
Drug-Drug Interaction Study of VX-770 and VX-809 in Healthy Subjects
CompletedNCT01216046
Start: 2010-10-31End: 2011-05-31Updated: 2012-01-18